BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 27990656)

  • 1. Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.
    Foj L; Ferrer F; Serra M; Arévalo A; Gavagnach M; Giménez N; Filella X
    Prostate; 2017 May; 77(6):573-583. PubMed ID: 27990656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of miRNAs in urine of prostate cancer patients.
    Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S
    Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
    Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L
    Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: Application for prostate cancer diagnostic.
    Samsonov R; Shtam T; Burdakov V; Glotov A; Tsyrlina E; Berstein L; Nosov A; Evtushenko V; Filatov M; Malek A
    Prostate; 2016 Jan; 76(1):68-79. PubMed ID: 26417675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue.
    Stephan C; Jung M; Rabenhorst S; Kilic E; Jung K
    Clin Chem Lab Med; 2015 Jun; 53(7):1109-18. PubMed ID: 25720086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes.
    Rodríguez M; Bajo-Santos C; Hessvik NP; Lorenz S; Fromm B; Berge V; Sandvig K; Linē A; Llorente A
    Mol Cancer; 2017 Oct; 16(1):156. PubMed ID: 28982366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of let-7c, miR-21, miR-145, miR-182, and miR-221 with clinicopathologic parameters of prostate cancer in patients diagnosed with low-risk disease.
    Kurul NO; Ates F; Yilmaz I; Narli G; Yesildal C; Senkul T
    Prostate; 2019 Jul; 79(10):1125-1132. PubMed ID: 31045265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
    Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
    PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cell-free microRNAs in the urine of patients with prostate cancer.
    Korzeniewski N; Tosev G; Pahernik S; Hadaschik B; Hohenfellner M; Duensing S
    Urol Oncol; 2015 Jan; 33(1):16.e17-16.e22. PubMed ID: 25445383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary-exosomal miR-2909: A novel pathognomonic trait of prostate cancer severity.
    Wani S; Kaul D; Mavuduru RS; Kakkar N; Bhatia A
    J Biotechnol; 2017 Oct; 259():135-139. PubMed ID: 28764970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
    Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
    Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNAs as novel biomarkers in the management of prostate cancer.
    Filella X; Foj L
    Clin Chem Lab Med; 2017 May; 55(5):715-736. PubMed ID: 26751899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of urine-circulating miRNAs for detection of prostate cancer.
    Stuopelyte K; Daniunaite K; Bakavicius A; Lazutka JR; Jankevicius F; Jarmalaite S
    Br J Cancer; 2016 Sep; 115(6):707-15. PubMed ID: 27490805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
    Barceló M; Castells M; Bassas L; Vigués F; Larriba S
    Sci Rep; 2019 Sep; 9(1):13772. PubMed ID: 31551516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for serum exosomal miRNAs analysis in prostate cancer patients treated with radiotherapy.
    Malla B; Aebersold DM; Dal Pra A
    J Transl Med; 2018 Aug; 16(1):223. PubMed ID: 30103771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased urinary exosomal microRNAs in children with idiopathic nephrotic syndrome.
    Chen T; Wang C; Yu H; Ding M; Zhang C; Lu X; Zhang CY; Zhang C
    EBioMedicine; 2019 Jan; 39():552-561. PubMed ID: 30467011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.
    Corcoran C; Rani S; O'Driscoll L
    Prostate; 2014 Sep; 74(13):1320-34. PubMed ID: 25053345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary exosomal microRNA profiling in intermediate-risk prostate cancer.
    Kim MY; Shin H; Moon HW; Park YH; Park J; Lee JY
    Sci Rep; 2021 Apr; 11(1):7355. PubMed ID: 33795765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers.
    Filella X; Foj L
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
    Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
    Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.